PRENW Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- —
- P/S (TTM)
- —
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- -31.8%
- Operating margin
- -33.3%
- Revenue growth YoY
- 248.6%
- Dividend yield
- —
- Beta
- 0.27
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Prenetics Holding Company Limited
Company profilePrenetics Holding Company Limited is a pioneering global healthcare technology firm dedicated to enhancing health outcomes through innovative genetic testing and digital health solutions. By offering a comprehensive suite of genetic screening and diagnostics, the company utilizes advanced technologies and data analytics to drive personalized medicine and deliver actionable health insights. As the market for precision health solutions continues to grow, Prenetics is strategically expanding its product offerings to seize emerging opportunities in a rapidly evolving, data-driven healthcare…
Classification
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- UNIT 703-706, K11 ATELIER KING?S ROAD, QUARRY BAY
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Educational content · Not investment advice or recommendations
We're educators, not advisors. Your decisions are your own. Disclaimer
I'm your AI thinking companion for the markets — I can help you explore and learn, but I'm not a financial advisor. Everything here is educational. Disclaimer